Susquehanna Portfolio Strategies »

Xeris Pharmaceuticals shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $479k 61k 7.92

More positions owned by Susquehanna Portfolio Strategies

Intel Corporation (INTC)
Abbvie (ABBV)
Sherwin-Williams Company (SHW)
Medtronic SHS (MDT)
Philip Morris International (PM)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Humana (HUM)
Prologis (PLD)
Williams Companies (WMB)
Devon Energy Corporation (DVN)
Equinix (EQIX)
Metropcs Communications (TMUS)
Monster Beverage Corp (MNST)
Cigna Corp (CI)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Xeris Pharmaceuticals

BlackRock
D. E. Shaw & Co
Vanguard Capital Management
Geode Capital Management
State Street Corporation
Nuveen
Rosalind Advisors
Qube Research & Technologies
Vanguard Portfolio Management
Morgan Stanley
Wellington Management Company
Legal & General Group
Armistice Capital
Two Sigma Investments
Parkman Healthcare Partners

View all funds holding Xeris Pharmaceuticals